In September 2019, Prof Lionel Tarassenko CBE was presented with an ‘Outstanding Achievement Award’ by Oxford Trust CEO, Steve Burgess, for his contribution to biomedical engineering and translational innovation in healthcare and technology systems, including work with Oxehealth.
Lightcast Discovery, was spun out of OTIF portfolio company Base4 Innovation in early 2019 to develop a next-generation microfluidic platform to revolutionise complex cell analysis. Today it announced the close of a £1.3m Seed round with investment from OTIF and other private investors to develop the capabilities and applications of its platform including continuing to expand its range of pilot studies.
OTIF portfolio company Keit Spectrometers has announced it has further established sales and support of the IRmadillo into Nordic countries
OTIF portfolio company Biofidelity was spun out of Base4 Innovation in early 2019 to develop high performance novel molecular assays for the sensitive detection of low-frequency genetic mutations.
Mario Polywka, the recently retired COO of pharma company Evotec, joined Orbit Discovery’s Board of Directors at the beginning of September 2019.